Tags: MultipleMyeloma, StemCellTransplant
Tags: JimmyFund, Melanoma, StemCellTransplant, Development
Tags: ChildhoodCancer, StemCellTransplant
Dr. Robert J. Soiffer and Dr. Matthew S. Davids led a study showing the immune checkpoint blocker ipilimumab showed clinical benefit in nearly half of blood cancer patients who had relapsed following allogeneic stem cell transplantation.
Tags: StemCellTransplant, Leukemia
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: